Approval · Notice of Compliance 23310 · 2020
ACT METHYLPHENIDATE ER: Notice of Compliance 23310
Issued March 3, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23310
- Date
- March 3, 2020
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Canadian reference product
- CONCERTA (Janssen Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT METHYLPHENIDATE ER | 02441934 | Marketed |
| ACT METHYLPHENIDATE ER | 02441942 | Marketed |
| ACT METHYLPHENIDATE ER | 02441950 | Marketed |
| ACT METHYLPHENIDATE ER | 02441969 | Marketed |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 18 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 27 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 36 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 54 MG per TAB